A generic alternative indicated for Cholesterol. Dual-action formulation reduces lipid absorption and lowers overall systemic low-density lipoprotein levels.
Indicated to address high cholesterol by targeting both liver production and intestinal absorption to support cardiovascular health and alleviate arterial risk factors.
Mechanism of Action
Rosuvastatin blocks the liver's ability to produce cholesterol. Ezetimibe prevents the small intestine from absorbing cholesterol from food. Together, they lower total and LDL 'bad' cholesterol levels more than either drug alone.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Active liver disease, Pregnancy, Breastfeeding, Severe renal impairment (caution)
Severe Adverse Events
Rhabdomyolysis (muscle breakdown), Liver failure, Pancreatitis, New onset diabetes, Severe allergic reactions
Information for Roszet is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
